BOSTON, Sept. 24, 2025) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully huma ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. “You wouldn’t worry so much about what others ...

"I'm satisfied with that result in so much as they have not managed to escape accountability. At least not yet." ...

Reacting to criticism over requiring nondisclosure agreements with Gillette officials, nuclear fuel manufacturing company BWXT said they were needed ...

CM04S1, a multi-antigen COVID-19 vaccine for immunocompromised individuals: clinical evaluation to date. For more information on the conference, please visit International Workshop on Chronic ...

Luckily, the experts at Adobe have presented an offering to even things out again. Their rollout of the Adobe Express design tool enables students to personalise their graphic art learning journey, ...

Halloween is just around the corner, and transforming your apartment into a spooky haven doesn’t have to drain your wallet. With a bit of creativity and some basic materials, you can create ...

Tiziana Life Sciences Announces Poster Presentation on Intranasal Foralumab Clinical Trial at the 41st ECTRIMS CongressBOSTON, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: ...

Merck has raised its dividend for 14 consecutive years and at an average pace of nearly 7% over the last five years. The current yield is ~4% and the payout ration is a very comfortable 41.4%.

Horror favorites like the 2012 anime series Another, which weaponizes classroom drama with chilling events one can never forget, and the infamous Higurashi: When They Cry, which is a deceptive good ...

Is there a "right" way to see Paul Thomas Anderson's latest? And, if so, does that mean there's also a "wrong" way? IndieWire's own film obsessives can't agree, but we sure have ideas and arguments to ...